Viemed Healthcare (VMD) Research & Development (2019 - 2026)
Viemed Healthcare (VMD) posted Research & Development of $579000.0 for Q1 2026, down 3.18% on a QoQ basis from $598000.0 in Q4 2025, and down 27.35% year-over-year from $797000.0 in Q1 2025.
Viemed Healthcare (VMD) Research & Development (2019 - 2026) Analysis & Trends
Viemed Healthcare's Research & Development history runs 8 years deep, the most recent figure standing at $579000.0 for Q1 2026.
- Quarterly Research & Development fell 27.35% year-over-year to $579000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 10.14% YoY) and the FY2025 annual result came in at $3.0 million, down 1.66% from the prior year.
- Research & Development was $579000.0 for Q1 2026 at Viemed Healthcare, down from $598000.0 in the prior quarter.
- Across five years, Research & Development topped out at $847000.0 in Q2 2025 and bottomed at $579000.0 in Q1 2026.
- A 5-year average of $714235.3 and a median of $750000.0 in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 86.43% — and 2026, when it decreased 27.35%.
- Viemed Healthcare's Research & Development stood at $722000.0 in 2022, then declined by 9.83% to $651000.0 in 2023, then advanced by 23.35% to $803000.0 in 2024, then declined by 25.53% to $598000.0 in 2025, then decreased by 3.18% to $579000.0 in 2026.
- Business Quant data shows VMD's Research & Development at $579000.0 in Q1 2026, $598000.0 in Q4 2025, and $775000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 579,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 579,000.00 |
| Dec 31, 2025 | 598,000.00 |
| Sep 30, 2025 | 775,000.00 |
| Jun 30, 2025 | 847,000.00 |
| Mar 31, 2025 | 797,000.00 |
| Dec 31, 2024 | 803,000.00 |
| Sep 30, 2024 | 757,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Mar 31, 2024 | 750,000.00 |
| Dec 31, 2023 | 651,000.00 |
| Sep 30, 2023 | 593,000.00 |
| Jun 30, 2023 | 758,000.00 |
| Mar 31, 2023 | 780,000.00 |
| Dec 31, 2022 | 722,000.00 |
| Sep 30, 2022 | 670,000.00 |
| Jun 30, 2022 | 672,000.00 |
| Mar 31, 2022 | 632,000.00 |
| Dec 31, 2021 | 612,000.00 |
| Sep 30, 2021 | 576,000.00 |
| Jun 30, 2021 | 583,000.00 |